openPR Logo
Press release

Global Osteoporosis Testing Market: Trends & Growth Forecast 2024-2031 | Major Companies - GE Healthcare, DMS Imaging, Swissray, BeamMed, Hologic

06-10-2025 12:12 PM CET | Health & Medicine

Press release from: DataM Intelligence 4 Market Research LLP

Osteoporosis Testing Market

Osteoporosis Testing Market

The Global Osteoporosis Testing Market reached USD 383.5 million in 2022 and is projected to witness lucrative growth by reaching up to USD 566.8 million by 2030. The global osteoporosis testing market is expected to exhibit a CAGR of 5.1% during the forecast period (2023-2030).

Osteoporosis Testing Market is comprehensively covered in the DataM Intelligence report, which offers critical data, industry trends, and market intelligence. The study delves into the competitive environment, assessing leading players on their product portfolios, pricing, financial health, strategic growth initiatives, and geographic expansion.

Unlock exclusive insights with our detailed sample report (Please enter your Corporate Email ID to get priority access) @ https://datamintelligence.com/download-sample/osteoporosis-testing-market?ca

Osteoporosis testing typically involves a bone mineral density (BMD) scan, most commonly using dual-energy X-ray absorptiometry (DXA) to measure bone strength and fracture risk. This quick, non-invasive test assesses key areas like the hip and spine, with results compared to healthy young adults (T-score) or age-matched peers (Z-score). Other methods include quantitative ultrasound (QUS) and CT scans, while risk assessments like FRAX® help evaluate fracture probability. Early detection through testing allows for lifestyle changes or treatments to prevent bone loss and fractures, especially in postmenopausal women and older adults.

Major players in the Osteoporosis Testing market

The prominent players in Osteoporosis Testing market research report are: GE Healthcare, DMS Imaging, Swissray, BeamMed, Hologic, OSTEOSYS, Scanflex Healthcare, CompuMed, FUJIFIL, and Trivitron Healthcare

The companies are primarily focusing on strategies such as new product launches to penetrate the fastest-growing emerging markets across the world.

Osteoporosis Testing Market Key Development

In 2022, the University Hospitals of Geneva (HUG) and the University of Geneva (UNIGE) introduced a novel blood-based diagnostic tool for assessing bone fragility, licensed by ProAxsis for use in Europe and Switzerland. Similarly, MEDIMAPS GROUP launched its AI-enhanced Trabecular Bone Score (TBS iNsight) on OsteoSys' DXA platforms, improving fracture risk prediction through advanced bone microarchitecture analysis. Both innovations offer non-invasive methods to enhance osteoporosis diagnosis-one via blood testing, the other through AI-powered imaging.

Meanwhile, the AMGA Foundation and Amgen took a different approach in 2021 with their Osteoporosis Best Practices Learning Collaborative, a year-long program focused on improving clinical strategies to reduce fractures. While not a diagnostic tool, this initiative emphasizes knowledge-sharing and systemic care improvements, complementing technological advancements like those from HUG, MEDIMAPS, and ProAxsis. Together, these developments highlight a multi-faceted push toward better osteoporosis management-through cutting-edge diagnostics and collaborative care optimization.

Speak to Our Senior Analyst and Get Customization in the report as per your requirements @ https://datamintelligence.com/customize/osteoporosis-testing-market?ca

Osteoporosis Testing Market Segments

By Type: X-Rays Scan, DEXA, FRAX Tool, Quantitative Ultrasound Scans

By End User: Hospital, Diagnostic Imaging Centers, Orthopedic Clinics, Ambulatory Surgery Centers

The Osteoporosis Testing industry is experiencing rapid growth, driven by advancements in medical technologies, increased demand for innovative therapies, and a rising focus on patient-centered care. As these sectors evolve, the need for comprehensive market analysis becomes crucial to understand trends, regulatory changes, and emerging opportunities.

Regions Covered:

The global Osteoporosis Testing Market report focuses on six major regions: North America, South America, Europe, Asia Pacific, the Middle East, and Africa.

☞ North America - US, Canada, Mexico

☞ Europe- Germany, Russia, UK, France, Italy, Rest of Europe

☞ Asia Pacific- China, India, Japan, Australia, Rest of Asia Pacific

☞ South America- Brazil, Argentina, Colombia, Rest of South America

☞ Middle East and Africa- Saudi Arabia, UAE, Oman, Bahrain, Qatar, Kuwait, Israel

This Report Covers:

✔ Go-to-market Strategy.

✔ Neutral perspective on the market performance.

✔Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, Market Access, and other significant analysis, as well as development status.

✔Customized regional/country reports as per request and country level analysis.

✔ Potential & niche segments and regions exhibiting promising growth covered.

✔ Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).

Stay informed with the latest industry insights-start your subscription now: https://www.datamintelligence.com/reports-subscription

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Osteoporosis Testing Market: Trends & Growth Forecast 2024-2031 | Major Companies - GE Healthcare, DMS Imaging, Swissray, BeamMed, Hologic here

News-ID: 4059285 • Views:

More Releases from DataM Intelligence 4 Market Research LLP

US Single Cell Omics Market Size and Trends 2025-2034: Market Poised for Rapid Growth with USD 28.88 Billion Opportunity in Precision Medicine
US Single Cell Omics Market Size and Trends 2025-2034: Market Poised for Rapid G …
The Global Single Cell Omics Market was valued at US$ 2.4 billion in 2022 and is projected to reach US$ 15.5 billion by 2032, growing at a CAGR of 20.2% during the forecast period.The market growth is driven by the rapid advancements in single-cell sequencing technologies, increasing investment in genomics and precision medicine, and growing applications in oncology, immunology, and neurobiology research. The rising need for high-resolution cellular analysis to
United States Slow Release & Controlled Release Fertilizer Market 2025 | Growth, Trends, Share & Forecast Analysis Till 2032
United States Slow Release & Controlled Release Fertilizer Market 2025 | Growth, …
According to DataM Intelligence Comprehensive Report has released its latest report on the "Slow Release and Controlled Release Fertilizers Market Size 2025," providing a detailed analysis of market trends, key growth drivers, competitive landscape, and regional insights. The report includes market size (value and volume), CAGR projections, and emerging opportunities that help businesses identify growth areas and build effective strategies. Backed by data-driven insights and future outlook, this study serves
United States Metallocene Polyethylene Market 2025: Industry Developments, Future Growth, Share & Industry Insights | Dow Chemical, ExxonMobil Corporation, Univation Technologies, Chevron Philips
United States Metallocene Polyethylene Market 2025: Industry Developments, Futur …
Global Metallocene polyethylene Market is expected to grow at a CAGR of 6.5% during the forecasting period 2024-2031. According to DataM Intelligence, the Metallocene Polyethylene (mPE) market is experiencing healthy demand growth as converters and brand owners seek higher-performance, downguageable films, improved sealability, and recyclable-friendly resin solutions. mPE's combination of narrow molecular weight distribution, enhanced toughness, puncture resistance and processability makes it a preferred choice for flexible packaging, agriculture films, construction
US Immune Health Probiotic Supplements Market Growth Forecast 2025-2031: Market Size to Reach USD 3.53 Billion with Rising Digestive and Immune Health Awareness
US Immune Health Probiotic Supplements Market Growth Forecast 2025-2031: Market …
The Global Immune Health Probiotic Supplements Market was valued at US$ 220.1 million in 2023 and is anticipated to reach US$ 394.6 million by 2031, registering a CAGR of 8.7% during the forecast period (2024-2031). Market expansion is primarily driven by the increasing adoption of preventive healthcare practices, rising awareness regarding immune resilience, and the growing incorporation of probiotic formulations into daily nutrition. Consumers are increasingly seeking clinically validated, microbiome-supportive

All 5 Releases


More Releases for Osteoporosis

Rising Prevalence Of Osteoporosis Fuels Growth In The Osteoporosis Drug Market: …
The Osteoporosis Drugs Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Osteoporosis Drugs Market Size During the Forecast Period? The market for medications for osteoporosis has seen a consistent rise in recent years. The current market value of $12.33 billion in 2024
Rising Prevalence Of Osteoporosis Spurs Momentum In Postmenopausal Osteoporosis …
The Postmenopausal Osteoporosis Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Current Postmenopausal Osteoporosis Treatment Market Size and Its Estimated Growth Rate? The market for treatment of postmenopausal osteoporosis has seen a steady increase in size over the recent years. It's projected
Osteoporosis Drug Market, By Type (Primary Osteoporosis and Secondary Osteoporos …
Osteoporosis is a condition of bone weakening or bones becomes fragile and likely to break. In other words, osteoporosis is a condition wherein the bone density decreases. This is specially witnessed in old age people. Osteoporosis brings along back pain, stooped posture, bone fracture and tooth loss. View Detailed Report" https://www.databridgemarketresearch.com/reports/global-osteoporosis-drug-market The global osteoporosis drug market is experiencing steady growth driven by factors such as the increasing aging population, rising prevalence of
Osteoporosis Drugs: The Complete Review
Medication for osteoporosis increases bone mineral density and reduces fracture risk. Some osteoporosis medications promote bone growth while others reduce bone loss. The bones may begin to deteriorate as age more quickly than the body can heal them. The doctor could determine that people have osteoporosis if they have significant bone density loss. To receive free sample pages of this report@ https://www.psmarketresearch.com/market-analysis/osteoporosis-drugs-market/report-sample Although osteoporosis cannot be treated, it can be slowed down or
Osteoporosis Drugs Market: Demand for Osteoporosis Drugs High Among Geriatric Po …
The global osteoporosis drugs market is analyzed in a report by Transparency Market Research (TMR). The market is expected to grow due to the increasing geriatric population across the globe. The market for osteoporosis drugs is considered semi-consolidated as a handful of players hold a larger share in the market. As per the analysis, Novartis International AG, Eli Lilly and Company, Merck & Co. Inc., Pfizer Inc., and Amgen Inc.
Global Postmenopausal Osteoporosis Therapeutics Market
The Postmenopausal Osteoporosis Therapeutics Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. Osteoporosis is an orthopedic condition where the bone density and bone mass decreases and eventually increases the risk of bone fracture. Osteoporosis is one of the most common age related